XORTX Therapeutics Inc (ANU) Q2 2023 Earnings Report
DE:ANU Q2 2023 EPS Results
- Actual EPS
- -EUR 3.61
- Consensus EPS
- -EUR 6.95
- Beat/Miss
- Beat by +EUR 3.33
- One Year Ago EPS
- -EUR 3.76
DE:ANU Q2 2023 Revenue Results
- Actual Revenue
- EUR 0
- Expected Revenue
- EUR 0
- Beat/Miss
- Met expectations
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2023
- Date
- 08/15/2023
- Time
- Before Open
- Conference Call
- Tuesday, August 15, 2023
DE:ANU Upcoming Earnings
XORTX Therapeutics Inc's next earnings date is estimated for November 12, 2026, based on past reporting schedules.
Q2 2023 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2023 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:ANU Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 12, 2026 | 2026 (Q3) | ―- | -0.58 | ― | ― |
| Aug 15, 2026 | 2026 (Q2) | ―-0.94 | -0.85 | -10.53% (-0.09) | |
| May 16, 2026 | 2026 (Q1) | ―-0.52 | -0.85 | 38.95% (+0.33) | |
| Mar 26, 2026 | 2025 (Q4) | -0.74-0.22 | -0.18 | -25.00% (-0.04) | |
| Nov 15, 2025 | 2025 (Q3) | -0.74-0.58 | -1.29 | 55.17% (+0.71) | |
| Aug 14, 2025 | 2025 (Q2) | ―-0.85 | 0.27 | -416.67% (-1.12) | |
| May 16, 2025 | 2025 (Q1) | ―-0.85 | -5.53 | 84.68% (+4.68) | |
| Mar 26, 2025 | 2024 (Q4) | -1.29-0.18 | 6.16 | -102.90% (-6.33) | |
| Nov 15, 2024 | 2024 (Q3) | ―-1.29 | -2.99 | 56.72% (+1.69) | |
| Aug 14, 2024 | 2024 (Q2) | -2.230.27 | -3.61 | 107.41% (+3.88) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
